Skip to main content
NIH funding notice PA-18-025

Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional)

Closed on May 7, 2020.

Posted
November 1, 2017
Close date
May 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $696,160 in first-year total cost, median $696,160.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BDCN-W (91)]1

Most frequent institutions

  1. OKLAHOMA MEDICAL RESEARCH FOUNDATION1
Competing awards under PA-18-025 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Does insulin sensitivity impact the potential of metformin to slow aging?1R01AG064951-01MILLER, BENJAMIN FRANCISOKLAHOMA MEDICAL RESEARCH FOUNDATION, OK$696,160ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.